OPRX logo

OptimizeRx (OPRX) Cash From Operations

Annual CFO

-$7.24 M
-$17.89 M-167.95%

December 31, 2023


Summary


Performance

OPRX Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherOPRXcash flowmetrics:

Quarterly CFO

$1.79 M
+$1.01 M+129.03%

September 30, 2024


Summary


Performance

OPRX Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherOPRXcash flowmetrics:

TTM CFO

-$1.57 M
+$318.00 K+16.88%

September 30, 2024


Summary


Performance

OPRX TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherOPRXcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

OPRX Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-167.9%+21.6%-186.0%
3 y3 years-14.7%+234.2%-315.7%
5 y5 years-1013.4%+219.4%+5.7%

OPRX Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-167.9%at low-56.1%+128.6%-114.7%+78.4%
5 y5-year-167.9%at low-56.1%+128.6%-114.7%+78.4%
alltimeall time-167.9%at low-56.1%+128.6%-114.7%+78.4%

OptimizeRx Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
$1.79 M(+129.0%)
-$1.57 M(-16.9%)
Jun 2024
-
$782.00 K(-63.1%)
-$1.88 M(-62.6%)
Mar 2024
-
$2.12 M(-133.8%)
-$5.04 M(-30.4%)
Dec 2023
-$7.24 M(-167.9%)
-$6.26 M(-524.8%)
-$7.24 M(-497.4%)
Sep 2023
-
$1.47 M(-162.2%)
$1.82 M(-52.2%)
Jun 2023
-
-$2.37 M(+2654.7%)
$3.81 M(-41.3%)
Mar 2023
-
-$86.00 K(-103.1%)
$6.49 M(-39.1%)
Dec 2022
$10.65 M(+1367.5%)
$2.80 M(-19.0%)
$10.65 M(+63.5%)
Sep 2022
-
$3.46 M(+1023.7%)
$6.52 M(+100.0%)
Jun 2022
-
$308.10 K(-92.4%)
$3.26 M(+3.8%)
Mar 2022
-
$4.08 M(-405.7%)
$3.14 M(+332.5%)
Dec 2021
$726.00 K(-111.5%)
-$1.33 M(-751.3%)
$726.10 K(-236.5%)
Sep 2021
-
$204.90 K(+7.9%)
-$532.00 K(-36.9%)
Jun 2021
-
$189.90 K(-88.6%)
-$843.50 K(-6.9%)
Mar 2021
-
$1.67 M(-164.3%)
-$905.80 K(-85.6%)
Dec 2020
-$6.31 M(+280.0%)
-$2.59 M(+2332.1%)
-$6.31 M(+20.9%)
Sep 2020
-
-$106.60 K(-183.5%)
-$5.22 M(-14.2%)
Jun 2020
-
$127.60 K(-103.4%)
-$6.08 M(-3.3%)
Mar 2020
-
-$3.74 M(+149.3%)
-$6.29 M(+278.7%)
Dec 2019
-$1.66 M(-309.5%)
-$1.50 M(+54.8%)
-$1.66 M(-315.2%)
Sep 2019
-
-$969.10 K(+1084.7%)
$771.90 K(-72.6%)
Jun 2019
-
-$81.80 K(-109.2%)
$2.82 M(+14.2%)
Mar 2019
-
$890.00 K(-4.6%)
$2.47 M(+211.6%)
Dec 2018
$792.60 K(-153.6%)
$932.80 K(-13.5%)
$792.60 K(-687.1%)
Sep 2018
-
$1.08 M(-350.0%)
-$135.00 K(-93.3%)
Jun 2018
-
-$431.50 K(-45.2%)
-$2.00 M(+1.7%)
Mar 2018
-
-$787.40 K(<-9900.0%)
-$1.97 M(+33.1%)
Dec 2017
-$1.48 M(+217.6%)
$5200.00(-100.7%)
-$1.48 M(-22.1%)
Sep 2017
-
-$788.90 K(+97.8%)
-$1.90 M(+93.0%)
Jun 2017
-
-$398.90 K(+34.2%)
-$984.60 K(+106.4%)
Mar 2017
-
-$297.20 K(-28.5%)
-$477.00 K(+2.4%)
Dec 2016
-$466.00 K
-$415.40 K(-427.3%)
-$465.90 K(+1891.0%)
Sep 2016
-
$126.90 K(+16.7%)
-$23.40 K(-125.5%)
Jun 2016
-
$108.70 K(-138.0%)
$91.60 K(-35.7%)
DateAnnualQuarterlyTTM
Mar 2016
-
-$286.10 K(-1155.7%)
$142.40 K(-72.4%)
Dec 2015
$515.10 K(-1014.9%)
$27.10 K(-88.8%)
$515.20 K(-32.3%)
Sep 2015
-
$241.90 K(+51.7%)
$760.90 K(+124.1%)
Jun 2015
-
$159.50 K(+84.0%)
$339.60 K(-272.9%)
Mar 2015
-
$86.70 K(-68.2%)
-$196.40 K(+248.2%)
Dec 2014
-$56.30 K(-105.0%)
$272.80 K(-252.1%)
-$56.40 K(-111.3%)
Sep 2014
-
-$179.40 K(-52.4%)
$500.40 K(-42.9%)
Jun 2014
-
-$376.50 K(-266.1%)
$876.30 K(-35.2%)
Mar 2014
-
$226.70 K(-72.7%)
$1.35 M(+19.4%)
Dec 2013
$1.13 M(-281.5%)
$829.60 K(+322.2%)
$1.13 M(+271.9%)
Sep 2013
-
$196.50 K(+96.7%)
$304.50 K(-314.4%)
Jun 2013
-
$99.90 K(+1436.9%)
-$142.00 K(-71.0%)
Mar 2013
-
$6500.00(+306.3%)
-$489.60 K(-21.6%)
Dec 2012
-$624.00 K(+19.7%)
$1600.00(-100.6%)
-$624.10 K(+15.0%)
Sep 2012
-
-$250.00 K(+0.9%)
-$542.80 K(-19.2%)
Jun 2012
-
-$247.70 K(+93.5%)
-$671.70 K(+20.4%)
Mar 2012
-
-$128.00 K(-254.4%)
-$557.90 K(+7.0%)
Dec 2011
-$521.50 K(-60.2%)
$82.90 K(-121.9%)
-$521.50 K(-12.5%)
Sep 2011
-
-$378.90 K(+183.0%)
-$595.70 K(-6.1%)
Jun 2011
-
-$133.90 K(+46.2%)
-$634.30 K(-45.4%)
Mar 2011
-
-$91.60 K(-1152.9%)
-$1.16 M(-11.3%)
Dec 2010
-$1.31 M(-25.9%)
$8700.00(-102.1%)
-$1.31 M(-17.9%)
Sep 2010
-
-$417.50 K(-37.0%)
-$1.60 M(+5.7%)
Jun 2010
-
-$662.20 K(+175.6%)
-$1.51 M(+13.6%)
Mar 2010
-
-$240.30 K(-13.3%)
-$1.33 M(-24.8%)
Dec 2009
-$1.77 M(+92.5%)
-$277.30 K(-16.4%)
-$1.77 M(-2.6%)
Sep 2009
-
-$331.70 K(-31.0%)
-$1.82 M(+7.3%)
Jun 2009
-
-$480.70 K(-29.3%)
-$1.69 M(+20.2%)
Mar 2009
-
-$679.90 K(+109.3%)
-$1.41 M(+53.2%)
Dec 2008
-$919.40 K(+202.8%)
-$324.80 K(+56.3%)
-$919.50 K(+54.6%)
Sep 2008
-
-$207.80 K(+6.1%)
-$594.70 K(+53.7%)
Jun 2008
-
-$195.80 K(+2.5%)
-$386.90 K(+102.5%)
Mar 2008
-
-$191.10 K
-$191.10 K
Dec 2007
-$303.60 K
-
-

FAQ

  • What is OptimizeRx annual cash flow from operations?
  • What is the all time high annual CFO for OptimizeRx?
  • What is OptimizeRx annual CFO year-on-year change?
  • What is OptimizeRx quarterly cash flow from operations?
  • What is the all time high quarterly CFO for OptimizeRx?
  • What is OptimizeRx quarterly CFO year-on-year change?
  • What is OptimizeRx TTM cash flow from operations?
  • What is the all time high TTM CFO for OptimizeRx?
  • What is OptimizeRx TTM CFO year-on-year change?

What is OptimizeRx annual cash flow from operations?

The current annual CFO of OPRX is -$7.24 M

What is the all time high annual CFO for OptimizeRx?

OptimizeRx all-time high annual cash flow from operations is $10.65 M

What is OptimizeRx annual CFO year-on-year change?

Over the past year, OPRX annual cash flow from operations has changed by -$17.89 M (-167.95%)

What is OptimizeRx quarterly cash flow from operations?

The current quarterly CFO of OPRX is $1.79 M

What is the all time high quarterly CFO for OptimizeRx?

OptimizeRx all-time high quarterly cash flow from operations is $4.08 M

What is OptimizeRx quarterly CFO year-on-year change?

Over the past year, OPRX quarterly cash flow from operations has changed by +$318.00 K (+21.59%)

What is OptimizeRx TTM cash flow from operations?

The current TTM CFO of OPRX is -$1.57 M

What is the all time high TTM CFO for OptimizeRx?

OptimizeRx all-time high TTM cash flow from operations is $10.65 M

What is OptimizeRx TTM CFO year-on-year change?

Over the past year, OPRX TTM cash flow from operations has changed by -$3.39 M (-185.98%)